
David A. Reifsnyder
Examiner (ID: 7507, Phone: (571)272-1145 , Office: P/1778 )
| Most Active Art Unit | 1723 |
| Art Unit(s) | 1797, 1778, 1776, 2899, 1723, 1306 |
| Total Applications | 2074 |
| Issued Applications | 1659 |
| Pending Applications | 148 |
| Abandoned Applications | 274 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7126966
[patent_doc_number] => 20050058710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Porous drug matrices and methods of manufacture thereof'
[patent_app_type] => utility
[patent_app_number] => 10/928886
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10762
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928886 | Porous drug matrices and methods of manufacture thereof | Aug 26, 2004 | Abandoned |
Array
(
[id] => 876370
[patent_doc_number] => 07358226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Ultrasonic concentration of drug delivery capsules'
[patent_app_type] => utility
[patent_app_number] => 10/928648
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 21094
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358226.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928648 | Ultrasonic concentration of drug delivery capsules | Aug 25, 2004 | Issued |
Array
(
[id] => 7436350
[patent_doc_number] => 20040266869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Novel medicament compositions based on anticholinesterase drugs and on ciclesonides'
[patent_app_type] => new
[patent_app_number] => 10/465921
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7380
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465921 | Novel medicament compositions based on anticholinesterase drugs and on ciclesonides | Aug 25, 2004 | Abandoned |
Array
(
[id] => 6966002
[patent_doc_number] => 20050232899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b'
[patent_app_type] => utility
[patent_app_number] => 10/927518
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9920
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10927518
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/927518 | Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b | Aug 24, 2004 | Abandoned |
Array
(
[id] => 7175803
[patent_doc_number] => 20050123486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Medical product containing tiotropium'
[patent_app_type] => utility
[patent_app_number] => 10/921192
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8686
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921192 | Medical product containing tiotropium | Aug 18, 2004 | Abandoned |
Array
(
[id] => 7026459
[patent_doc_number] => 20050020502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Sincalide formulations'
[patent_app_type] => utility
[patent_app_number] => 10/921732
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15539
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921732 | Sincalide formulations | Aug 18, 2004 | Abandoned |
Array
(
[id] => 5590418
[patent_doc_number] => 20060039869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Intranasal delivery of antipsychotic drugs'
[patent_app_type] => utility
[patent_app_number] => 10/920153
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4299
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920153 | Intranasal delivery of antipsychotic drugs | Aug 16, 2004 | Abandoned |
Array
(
[id] => 7249098
[patent_doc_number] => 20040258623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Insulin-containing oral spray and the preparation method thereof'
[patent_app_type] => new
[patent_app_number] => 10/486461
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2942
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486461
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486461 | Insulin-containing oral spray and the preparation method thereof | Aug 12, 2004 | Abandoned |
Array
(
[id] => 7265099
[patent_doc_number] => 20040242635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Encapsulated dyes in cosmetic compositions'
[patent_app_type] => new
[patent_app_number] => 10/432762
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1918
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432762 | Encapsulated dyes in cosmetic compositions | Aug 5, 2004 | Abandoned |
Array
(
[id] => 363186
[patent_doc_number] => 07481996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Aerosol cosmetic composition'
[patent_app_type] => utility
[patent_app_number] => 10/911488
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7111
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/481/07481996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10911488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/911488 | Aerosol cosmetic composition | Aug 4, 2004 | Issued |
Array
(
[id] => 7199856
[patent_doc_number] => 20050042179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine'
[patent_app_type] => utility
[patent_app_number] => 10/909619
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3872
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042179.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909619 | Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7199858
[patent_doc_number] => 20050042180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder'
[patent_app_type] => utility
[patent_app_number] => 10/909624
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5440
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909624 | Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7127899
[patent_doc_number] => 20050059643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Medicaments for inhalation comprising a steroid and a betamimetic'
[patent_app_type] => utility
[patent_app_number] => 10/903769
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7470
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059643.pdf
[firstpage_image] =>[orig_patent_app_number] => 10903769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/903769 | Medicaments for inhalation comprising a steroid and a betamimetic | Jul 29, 2004 | Abandoned |
Array
(
[id] => 7206293
[patent_doc_number] => 20050043247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative'
[patent_app_type] => utility
[patent_app_number] => 10/902305
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4166
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902305
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902305 | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7199853
[patent_doc_number] => 20050042178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder'
[patent_app_type] => utility
[patent_app_number] => 10/901791
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4905
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901791
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901791 | Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7159422
[patent_doc_number] => 20050084457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Capsules containing inhalable tiotropium'
[patent_app_type] => utility
[patent_app_number] => 10/901790
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6565
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901790 | Capsules containing inhalable tiotropium | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7192745
[patent_doc_number] => 20050163725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Method for administration of growth hormone via pulmonary delivery'
[patent_app_type] => utility
[patent_app_number] => 10/900992
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5607
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163725.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900992 | Method for administration of growth hormone via pulmonary delivery | Jul 27, 2004 | Abandoned |
Array
(
[id] => 860456
[patent_doc_number] => 07371727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'Methods and compositions for the treatment of gastrointestinal disorders'
[patent_app_type] => utility
[patent_app_number] => 10/899806
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 33985
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899806 | Methods and compositions for the treatment of gastrointestinal disorders | Jul 26, 2004 | Issued |
Array
(
[id] => 7199852
[patent_doc_number] => 20050042177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Novel compositions of sildenafil free base'
[patent_app_type] => utility
[patent_app_number] => 10/895405
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17297
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895405 | Novel compositions of sildenafil free base | Jul 20, 2004 | Abandoned |
Array
(
[id] => 6971242
[patent_doc_number] => 20050036952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Compositions and methods for the treatment of aches and pains'
[patent_app_type] => utility
[patent_app_number] => 10/895243
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5284
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20050036952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895243 | Compositions and methods for the treatment of aches and pains | Jul 18, 2004 | Abandoned |